News summary

Why Male Mice Lose Anti-Cancer Immunity Earlier

Source: Lifespan.io • Published: 03 Nov 2026, 15:51

Summarized by Masters of Longevity from Lifespan.io.

Middle-aged male mice showed earlier naive CD8+ T cell loss and poorer tumor control.

Why Male Mice Lose Anti-Cancer Immunity Earlier
Key Takeaways
  • Male mice were reported to lose naive CD8+ T cells earlier.
  • Lymph nodes were found to shrink earlier in male mice.
  • Androgen suppression was shown to restore naive CD8+ T cells.
Read the full article at Lifespan.io ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?